Just over 2 weeks ago, we announced the launch of Cobroxin, a pain reliever developed by our subsidiary, ReceptoPharm. Since making that announcement, we have been inundated with calls and emails asking us about Cobroxin and our launch strategy. To help answer these questions, I have put together the following list of some of the […]
|
||||
|
||||||
